Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

April 28, 2014

Payers Wrestle with Reimbursement

Healthcare coverage for genomic tests in the clinic is at issue.

Payers Wrestle with Reimbursement

Medicare administrative contractors cut 2014 reimbursement rates for many molecular tests on average by 25% to 35%. [© vichie81 - Fotolia.com]

How private and public payers reimburse for tests is arguably the steepest hurdle to adoption of genomics by clinical practices Yet reimbursement policies are unlikely to move beyond quick fixes soon, while regulators, test developers, providers and payers wrestle with three questions: Who pays? How much? And what tests are ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.

Related content